Analyzing the Results of the Treating to New Targets Study
TO THE EDITOR:
In their secondary analysis of the TNT study, Wenger and colleagues (1) concluded that the findings support the use of intensive low-density lipoprotein cholesterol–lowering therapy in elderly individuals with established cardiovascular disease (1). Close scrutiny of the data contradicts their conclusion.
The secondary analysis of the TNT study compared the outcomes of 10 mg with 80 mg of …
RSS Feeds









